ByteBrief

Best read upright.

We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.

(We tried widescreen once. It wasn't us.)

ByteBrief

AIFinancial Timesabout 3 hours ago

Insilico Starts Phase III Trial for Rentosertib

1 min read

Insilico Medicine initiated a Phase III clinical trial for Rentosertib, an AI-empowered TNIK inhibitor targeting idiopathic pulmonary fibrosis. The trial evaluates the drug's efficacy and safety in patients. Rentosertib was discovered using Insilico's artificial intelligence platform for drug development.

Level

Hype check

Tap to vote and see what everyone thinks.

#insilico #rentosertib #clinical trial